Approximately six grants worth up to CA$1,170,000 each will be awarded to joint Canadian-Israeli biomedical science research teams for a period of up to three years.
These grants will support Canadian and Israeli researchers, who will work with collaborators from low- and middle-income countries, to explore new frontiers in overcoming therapeutic resistance in high fatality cancers. Potential research topics can include, but are not limited to:
- tumor heterogeneity
- novel approaches to cancer therapy
- predictive models of cancer
- tumor microenvironments
- cancer-related biochemical signalling networks
- cancer metabolism
- pathogenesis of infection associated cancers
Applicants must include a plan for integrating researchers from low- and middle-income countries that will establish long-term scientific relationships. Such plans can include a range of activities that support the proposal’s research and training objectives and leverage this funding opportunity to design a collaborative international research project.
The application for this funding opportunity is a two-step process that requires registration and application.
Registration deadline: January 17, 2017
Application deadline: February 14, 2017
Read more about the call, guidelines for submission and the application process.